← Back to Search

Assessment Tool for Cancer Care Planning

N/A
Waitlist Available
Led By Dale William, MD
Research Sponsored by City of Hope Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Pathologically confirmed cancer
Receiving chemotherapy for either adjuvant treatment or metastatic disease prior to beginning a new chemotherapy regimen
Timeline
Screening 3 weeks
Treatment Varies
Follow Up prior to chemotherapy and within 30 days of completion of chemotherapy.
Awards & highlights

Study Summary

This trial is studying an assessment tool to help doctors plan treatment for older patients with cancer.

Who is the study for?
This trial is for older adults with any type of cancer who are about to start a new chemotherapy regimen. They must have confirmed cancer, understand English, and not be enrolled in another phase I clinical trial or this trial previously.Check my eligibility
What is being tested?
The study is testing an assessment tool designed to evaluate cognitive functions and daily activity abilities in older cancer patients. This includes understanding how they think, learn, remember, make judgments during their treatment process.See study design
What are the potential side effects?
Since the interventions involve assessments rather than medications (like cognitive tests and questionnaires), there aren't typical medication side effects; however, participants may experience stress or discomfort from discussing their condition.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~prior to chemotherapy and within 30 days of completion of chemotherapy.
This trial's timeline: 3 weeks for screening, Varies for treatment, and prior to chemotherapy and within 30 days of completion of chemotherapy. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Ability to predict toxicity to chemotherapy, defined as grade 3-4 toxicity, hospitalization, dose delay or reduction, or discontinuation of chemotherapy due to toxicity, as measured by a geriatric assessment tool
Secondary outcome measures
Longitudinal impact of cancer and chemotherapy treatment on geriatric assessment parameters

Trial Design

1Treatment groups
Experimental Treatment
Group I: Geriatric Assessment ToolExperimental Treatment3 Interventions
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
cognitive assessment
2005
Completed Phase 3
~1210
psychosocial assessment and care
2003
Completed Phase 4
~9920

Find a Location

Who is running the clinical trial?

City of Hope Medical CenterLead Sponsor
558 Previous Clinical Trials
1,916,390 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,609 Previous Clinical Trials
40,914,584 Total Patients Enrolled
Dale William, MDPrincipal InvestigatorCity of Hope Medical Center

Media Library

psychosocial assessment and care Clinical Trial Eligibility Overview. Trial Name: NCT00477958 — N/A
Psychosocial Impact of Cancer Research Study Groups: Geriatric Assessment Tool
Psychosocial Impact of Cancer Clinical Trial 2023: psychosocial assessment and care Highlights & Side Effects. Trial Name: NCT00477958 — N/A
psychosocial assessment and care 2023 Treatment Timeline for Medical Study. Trial Name: NCT00477958 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How widely distributed is this medical trial?

"This trial is available at the Wake Forest University Comprehensive Cancer Center in Winston-Salem, North carolina; Yale Cancer Center in New Haven, Connecticut; James P. Wilmot Cancer Center at University of Rochester Medical center in Rochester, NY and 8 other medical sites across the country."

Answered by AI

Who might be a likely candidate for participation in this experiment?

"This clinical trial seeks 750 participants with cancer between the ages of 65 and 120. To join, they must have a confirmed diagnosis, be undergoing chemotherapy before beginning this study, comprehend English well enough to understand instructions given to them by personnel onsite, not previously enrolled in this research project and currently uninvolved in any other phase I trials."

Answered by AI

Is this medical trial open to those aged 65 or older?

"This trial allows individuals aged 65 to 120 years old to register. There are 4 trials meant for youths, and 43 options available for the elderly population."

Answered by AI

Is there availability for participants in this experiment?

"Per the information on clinicaltrials.gov, this particular study is no longer looking for participants as its last edit was made in March of 2022. However, 45 other trials are currently open and recruiting new patients."

Answered by AI
~58 spots leftby Mar 2025